PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “United States Dept. of Health and Human Services”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1979

Nutrition in the Humphrey tradition.

This is only a partial overview of some of the activities within DHEW related to nutrition, with a particular focus on the Nutrition Coordinating Committee. Although the activities are already broad, they will expand as we identify additional problems and decide on appropriate solutions. Let me call on the members of The American Dietetic Association to assist us in our efforts to assign priorities to our activity. My discussion began with nutrition education, because this is a priority for both The American Dietetic Association and DHEW. We would welcome your help now and in the future as we attempt to make our programs in nutrition education and information more effective, more available, and more responsive to the needs of the American people. Nutrition in the Humphrey tradition is alive and well in DHEW.

Food Labeling↗
PubMed1978

Washington report.

Explore the source record for details and available documents.

Administrative Personnel↗
PubMed1979

The drug regulation process and the challenge of regulatory reform.

After 17 years of experience with the far-reaching 1962 amendments to the law regulating new drugs, a major effort is underway to overhaul the law. Important questions of health policy are involved. An extensive recent study by the Department of Health, Education, and Welfare's Review Panel on New Drug Regulation concluded that the system of regulation that requires governmental pre-market clearance of prescription drugs, based on evidence of safety and effectiveness, is fundamentally sound. But the Review Panel identified four principal deficiencies in the drug approval process: a lack of openness and public accountability, an inadequate science environment at the Food and Drug Administration (FDA), imprecision in the standards and procedures for pre-market approval, and limited FDA authority in the post-marketing period. Former FDA commissioner Donald Kennedy took useful administrative steps to mitigate these problems, but legislation is badly needed. Although the bill that recently passed the Senate is not perfect, it contains substantial improvements over the status quo and merits support.

Drug Evaluation↗